Long-term efficacy of brodalumab in ustekinumab-responsive patients with moderate-to-severe psoriasis

被引：0
|
作者：
Green, Lawrence [1 ]
Hsu, Sylvia [2 ]
Papp, Kim A. [3 ]
Rastogi, Shipra [4 ]
Pillai, Radhakrishnan [5 ]
Israel, Robert J. [6 ]
机构：
[1] George Washington Univ, Sch Med, Washington, DC 20052 USA
[2] Temple Univ, Sch Med, Philadelphia, PA 19122 USA
[3] Prob Med Res, Waterloo, ON, Canada
[4] Ortho Dermatol, Bridgewater, MA USA
[5] Dow Pharmaceut Sci, Petaluma, CA USA
[6] Valeant Pharmaceut North Amer, Bridgewater, MA USA
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2018年 / 79卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
6832
引用
收藏
页码：AB181 / AB181
页数：1
相关论文
共 50 条
  • [1] Long-term efficacy of ustekinumab in moderate-to-severe psoriasis
    Kimball, A. B.
    Gordon, K. B.
    Fakharzadeh, S.
    Yeilding, N.
    Szapary, P. O.
    Schenkel, B.
    Guzzo, C.
    Li, S.
    Papp, K. A.
    BRITISH JOURNAL OF DERMATOLOGY, 2012, 166 (04)
  • [2] Long-term clinical safety and efficacy of brodalumab in the treatment of Japanese patients with moderate-to-severe plaque psoriasis
    Umezawa, Y.
    Nakagawa, H.
    Niiro, H.
    Ootaki, K.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2016, 30 (11) : 1957 - 1960
  • [3] Long-term outcomes of ustekinumab in patients with moderate-to-severe psoriasis in a university hospital
    Ossorio-Garcia, Lidia
    Collantes-Rodriguez, Cristina
    Jimenez-Gallo, David
    Linares-Barrios, Mario
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2018, 79 (03) : AB179 - AB179
  • [4] Efficacy and safety of brodalumab versus ustekinumab in obese and nonobese patients with moderate-to-severe plaque psoriasis
    Yamauchi, Paul
    Elewski, Boni
    Wu, Jashin J.
    Rastogi, Shipra
    Israel, Robert J.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2018, 79 (03) : AB119 - AB119
  • [5] Long-term efficacy of brodalumab for the treatment of moderate-to-severe psoriasis in two pivotal phase 3 clinical trials
    Lebwohl, Mark
    Papp, Kim A.
    Tyring, Stephen
    Krueger, James
    Rastogi, Shipra
    Pillai, Radhakrishnan
    Israel, Robert J.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2018, 79 (03) : AB180 - AB180
  • [6] Long-term efficacy of ustekinumab in patients with moderate-to-severe psoriasis treated for up to 5 years in the PHOENIX 1 study
    Kimball, A. B.
    Papp, K. A.
    Wasfi, Y.
    Chan, D.
    Bissonnette, R.
    Sofen, H.
    Yeilding, N.
    Li, S.
    Szapary, P.
    Gordon, K. B.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2013, 27 (12) : 1535 - 1545
  • [7] Dermatology Life Quality Index in Patients with Moderate-to-Severe Plaque Psoriasis Treated with Brodalumab or Ustekinumab
    Lambert, Jo
    Hansen, Jes Birger
    Sohrt, Anne
    Puig, Luis
    DERMATOLOGY AND THERAPY, 2021, 11 (04) : 1265 - 1275
  • [8] Dermatology Life Quality Index in Patients with Moderate-to-Severe Plaque Psoriasis Treated with Brodalumab or Ustekinumab
    Jo Lambert
    Jes Birger Hansen
    Anne Sohrt
    Luis Puig
    Dermatology and Therapy, 2021, 11 : 1265 - 1275
  • [9] Long-term efficacy and safety of guselkumab in Chinese patients with moderate-to-severe plaque psoriasis
    Zheng, Jianfeng
    Chen, Wenjuan
    Yi, Xuemei
    Yu, Ning
    Ding, Yangfeng
    Gao, Yunlu
    FRONTIERS IN MEDICINE, 2023, 10
  • [10] Efficacy and safety of ustekinumab in the treatment of patients affected by moderate-to-severe psoriasis
    Talamonti, M.
    Galluzzo, M.
    Teoli, M.
    Bavetta, M.
    Chimenti, S.
    Costanzo, A.
    BRITISH JOURNAL OF DERMATOLOGY, 2011, 165 (06) : E34 - E34
12345